Internal Medicine

Investigators find individuals with asthma who slept less than 5 hours per night had increased asthma attacks and overnight hospitalizations.

A new research letter has found declines in rural areas have not been as pronounced as declines in metropolitan areas.

Investigators find bowel wall abnormalities in 31% of CT scans conducted in a 412 patient study.

New research suggests a group of 6 cancer biomarkers was associated with all-cause mortality and HF hospitalizations.

A discussion on unanswered questions and concerns among clinicians related to sickle cell disease and the ongoing COVID-19 pandemic.

Because symptoms can manifest differently in each patient, some individuals with schizophrenia have handled social isolation better than others.

Since the beginning of the COVID-19 pandemic most non-urgent medical appointments have been conducted using telehealth.

The latest scientific statement from the association highlights the importance of healthy diet at a young age on preventing CVD later in life.

With the majority of the scientific research community focused, a COVID-19 vaccine could be on the horizon.

While recent data regarding remdesivir has been positive, there is still a need for medications in pill form to treat COVID-19 infections.

How community, prevention, and research-based practice could be influenced by the pandemic.

Panagis Galiatsatos, MD, MHS, joins to discuss the underlying issues and potential solutions to COVID-19 patient disparities.

A combination of medications and therapy is viewed as the most effective method of treating schizophrenia.

Why the virus is burdening US populations similar to other diseases.

The Florida-based clinician shares perspective and insight into what should be prioritized or revised in specialty care.

A physician's assistant for Oasis Lifecare discusses some of the new and promissing treatments for schizophrenia.

Investigators found 30 mg of apremilast results in a significant reduction in plaque psoriasis patients.

Individuals who commonly eat popcorn and drink milk have smaller odds of developing IBD.

Research from ARVO 2020 suggest a 4-minute educational video could more than double compliance with patching in pediatric patients with ambylopia.

Flortaucipir PET tracer’s can identify high levels of neuropathologic changes and neurofibrillary tangles.

Discussing how end of study results from the phase 2 LADDER trial inform clinicians on the use of PDS with ranibizumab.

A new study finds a multitude of factors involving organizational, interpersonal, and intrapersonal influences lead to trauma in frontline caregivers.

A majority NASH patients receiving 0.4 mg of subcutaneous semaglutide has disease resolution following the 72-week phase 2 study.

An assessment of survey data show patients with severe depressive or psychological symptoms are more likely to be dissatisfied with their dermatologist.

In a new study, investigators discover fewer adverse events in patients taking 1 × 109 non-viable B bifidum HI-MIMBb75 cells than for patients taking a placebo.